DK0584136T3 - Bestemmelse af peptidmotiver på MHC-molekyler - Google Patents

Bestemmelse af peptidmotiver på MHC-molekyler

Info

Publication number: DK0584136T3
Authority: DK; Denmark
Prior art keywords: peptide motifs; pct; determination; date; mhc molecules
Prior art date: 1991-05-17

Application number

DK92909723T

Other languages

English (en)

Inventor

Olaf Ritzschke

Stefan Stevanovic

Hans-Georg Rammensee

Kirsten Falk

Guenther Jung

Original Assignee

Max Planck Gesellschaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-17

Filing date

1992-05-15

Publication date

2000-05-22

1991-05-17 Priority claimed from DE19914116256 external-priority patent/DE4116256C2/de

1992-05-15 Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft

2000-05-22 Application granted granted Critical

2000-05-22 Publication of DK0584136T3 publication Critical patent/DK0584136T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56977—HLA or MHC typing
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Cell Biology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Urology & Nephrology (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Organic Chemistry (AREA)
Biotechnology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
Food Science & Technology (AREA)
Zoology (AREA)
Microbiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Biophysics (AREA)
Pharmacology & Pharmacy (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Genetics & Genomics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

DK92909723T 1991-05-17 1992-05-15 Bestemmelse af peptidmotiver på MHC-molekyler DK0584136T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19914116256 DE4116256C2 (de)	1991-05-17	1991-05-17	Bestimmung von Peptidmotiven auf MHC-Molekülen
PCT/EP1992/001072 WO1992021033A1 (de)	1991-05-17	1992-05-15	Bestimmung von peptidmotiven auf mhc-molekülen

Publications (1)

Publication Number	Publication Date
DK0584136T3 true DK0584136T3 (da)	2000-05-22

Family

ID=6431930

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK92909723T DK0584136T3 (da)	1991-05-17	1992-05-15	Bestemmelse af peptidmotiver på MHC-molekyler

Country Status (10)

Country	Link
US (1)	US5747269A (da)
EP (1)	EP0584136B1 (da)
JP (2)	JP3424752B2 (da)
AT (1)	ATE189527T1 (da)
AU (1)	AU1694392A (da)
CA (2)	CA2103148C (da)
DE (2)	DE4143467C2 (da)
DK (1)	DK0584136T3 (da)
ES (1)	ES2145007T3 (da)
WO (1)	WO1992021033A1 (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7252829B1 (en)	1998-06-17	2007-08-07	Idm Pharma, Inc.	HLA binding peptides and their uses
US7611713B2 (en) *	1993-03-05	2009-11-03	Pharmexa Inc.	Inducing cellular immune responses to hepatitis B virus using peptide compositions
CA2141960A1 (en) *	1992-08-07	1994-02-17	Ralph T. Kubo	Hla binding peptides and their uses
US9340577B2 (en)	1992-08-07	2016-05-17	Epimmune Inc.	HLA binding motifs and peptides and their uses
DE4238416A1 (de) *	1992-11-13	1994-05-19	Max Planck Gesellschaft	Bestimmung von Peptidmotiven auf MHC-Molekülen
DE4423392A1 (de) *	1994-07-04	1996-01-11	Birsner & Grob Biotech Gmbh	Verfahren zur Identifizierung antigener Peptide
US6413517B1 (en)	1997-01-23	2002-07-02	Epimmune, Inc.	Identification of broadly reactive DR restricted epitopes
US6977074B2 (en)	1997-07-10	2005-12-20	Mannkind Corporation	Method of inducing a CTL response
US6994851B1 (en)	1997-07-10	2006-02-07	Mannkind Corporation	Method of inducing a CTL response
US20030138808A1 (en) *	1998-02-19	2003-07-24	Simard John J.L.	Expression vectors encoding epitopes of target-associated antigens
US6379970B1 (en) *	1999-04-30	2002-04-30	The Arizona Board Of Regents On Behalf Of The University Of Arizona	Analysis of differential protein expression
DE19925199A1 (de) *	1999-06-01	2000-12-07	Medigene Ag	Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
DE19925235A1 (de)	1999-06-01	2000-12-07	Medigene Ag	Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
CA2377525A1 (en) *	1999-07-19	2001-03-29	Epimmune, Inc.	Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions
ATE445643T1 (de)	1999-11-18	2009-10-15	Pharmexa Inc	Heteroklitische analoga von klasse-i epitopen
US7026443B1 (en)	1999-12-10	2006-04-11	Epimmune Inc.	Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
US7462354B2 (en)	1999-12-28	2008-12-09	Pharmexa Inc.	Method and system for optimizing minigenes and peptides encoded thereby
US7297330B2 (en) *	2000-02-04	2007-11-20	Thomas Jefferson University	Low dose haptenized tumor cell and tumor cell extract immunotherapy
US6861234B1 (en) *	2000-04-28	2005-03-01	Mannkind Corporation	Method of epitope discovery
US20030215425A1 (en) *	2001-12-07	2003-11-20	Simard John J. L.	Epitope synchronization in antigen presenting cells
AU2001257410B8 (en) *	2000-04-28	2006-12-21	Mannkind Corporation	Method of identifying and producing antigen peptides and use thereof as vaccines
US7919467B2 (en) *	2000-12-04	2011-04-05	Immunotope, Inc.	Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
EP2314712B1 (en) *	2001-11-07	2014-01-08	Mannkind Corporation	Expression vectors encoding epitopes of antigens and methods for their design
US20050221350A1 (en)	2002-05-29	2005-10-06	Toni Weinschenk	Method for identifying immunoreactive peptides
US9090673B2 (en)	2003-12-12	2015-07-28	City Of Hope	Synthetic conjugate of CpG DNA and T-help/CTL peptide
US20060153844A1 (en) *	2004-12-29	2006-07-13	Thomas Kundig	Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs
EP1882187A4 (en) *	2005-05-12	2010-10-20	Merck Sharp & Dohme	SYSTEM AND METHOD FOR THE AUTOMATED SELECTION OF T-CELL EPITOPES
EP1885393A4 (en)	2005-05-18	2011-03-02	Childrens Hosp & Res Ct Oak	METHODS AND COMPOSITIONS FOR IMMUNIZATION AGAINST CHLAMYDIA INFECTIONS
US20070248628A1 (en) *	2005-12-06	2007-10-25	Keller Lorraine H	Immunogens in cancer stem cells
US20080107668A1 (en) *	2006-08-30	2008-05-08	Immunotope, Inc.	Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
WO2008100598A2 (en)	2007-02-15	2008-08-21	Mannkind Corporation	A method for enhancing t cell response
JP2010528591A (ja) *	2007-05-23	2010-08-26	マンカインドコーポレイション	マルチシストロン性ベクター及びそれらの設計方法
WO2010086294A2 (en)	2009-01-28	2010-08-05	Epimmune Inc.	Pan-dr binding polypeptides and uses thereof
MX2012004721A (es)	2009-10-23	2012-06-25	Mannkind Corp	Inmunoterapia de cancer y metodo de tratamiento.
CA2984643A1 (en)	2015-05-13	2016-11-17	Agenus Inc.	Vaccines for treatment and prevention of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE126237T1 (de) *	1987-01-30	1995-08-15	Univ Leland Stanford Junior	Lymphocyteninhibierung durch hla-peptide.
IL92629A0 (en) *	1989-12-10	1990-08-31	Yeda Res & Dev	Direct binding of t-cell epitopes to mhc gene products on intact living antigen presenting cells and the use thereof for identifying epitopes causing autoimmune diseases and pharmaceutical compositions for treating such diseases

1991
- 1991-05-17 DE DE4143467A patent/DE4143467C2/de not_active Expired - Fee Related
1992
- 1992-04-15 US US08/146,145 patent/US5747269A/en not_active Expired - Fee Related
- 1992-05-15 EP EP92909723A patent/EP0584136B1/de not_active Expired - Lifetime
- 1992-05-15 DK DK92909723T patent/DK0584136T3/da active
- 1992-05-15 AT AT92909723T patent/ATE189527T1/de not_active IP Right Cessation
- 1992-05-15 CA CA002103148A patent/CA2103148C/en not_active Expired - Fee Related
- 1992-05-15 CA CA002471093A patent/CA2471093A1/en not_active Abandoned
- 1992-05-15 JP JP50920192A patent/JP3424752B2/ja not_active Expired - Fee Related
- 1992-05-15 AU AU16943/92A patent/AU1694392A/en not_active Abandoned
- 1992-05-15 WO PCT/EP1992/001072 patent/WO1992021033A1/de active IP Right Grant
- 1992-05-15 ES ES92909723T patent/ES2145007T3/es not_active Expired - Lifetime
- 1992-05-15 DE DE59209810T patent/DE59209810D1/de not_active Expired - Fee Related
2002
- 2002-12-09 JP JP2002357021A patent/JP2003176300A/ja not_active Ceased

Also Published As

Publication number	Publication date
JPH06510850A (ja)	1994-12-01
US5747269A (en)	1998-05-05
ATE189527T1 (de)	2000-02-15
DE4143467C2 (de)	1995-02-09
CA2103148A1 (en)	1992-11-18
AU1694392A (en)	1992-12-30
DE59209810D1 (de)	2000-03-09
JP3424752B2 (ja)	2003-07-07
WO1992021033A1 (de)	1992-11-26
EP0584136A1 (de)	1994-03-02
CA2471093A1 (en)	1992-11-26
EP0584136B1 (de)	2000-02-02
JP2003176300A (ja)	2003-06-24
ES2145007T3 (es)	2000-07-01
CA2103148C (en)	2004-07-20

Publication	Publication Date	Title
DK0584136T3 (da)	2000-05-22	Bestemmelse af peptidmotiver på MHC-molekyler
DK0696297T3 (da)	1999-05-10	Pyridobisimidazolbaseret stiv stavpolymer
DK0669001T3 (da)	1998-05-04	Bestemmelse af peptidmotiver på MHC-molekyler
FI941022A (fi)	1994-09-05	Spirosykliset piperidiinijohdannaiset
DK0912176T3 (da)	2003-01-13	Anvendelse af pyridylalkan-, pyridylalken- og/eller pyridylalkynsyreamider til behandling af tumorer eller immunosuppression
DE59204623D1 (de)	1996-01-18	Lagerstabile, permanent wasserbenetzbare vulkanisate ergebende polysiloxanmasse.
NO971766D0 (no)	1997-04-17	Anvendelsen av dioksomorfoliner for bekjempning av endoparasitter, nye dioksomorfoliner samt deres fremstilling
ATE263157T1 (de)	2004-04-15	Nematizide trifluorbutene
DK0473671T3 (da)	1994-09-19	Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel
ES2184077T3 (es)	2003-04-01	Nuevas fenantridinas sustituidas en la posicion 6.
TR199900501T2 (xx)	1999-07-21	Benzamin t�revleri ve bunlar�n ila� olarak kullan�m�.
NO934680L (no)	1993-12-17	Herdbare organopolysiloksanmasser
DK7191A (da)	1991-06-04	Topisk salve
ATE112239T1 (de)	1994-10-15	Vaterit und verfahren zu dessen herstellung.
DE69225410D1 (de)	1998-06-10	Herstellung von n-acetylneuraminsäure-derivaten
HUT77631A (hu)	1998-06-29	Eljárás a levobupivakain és származékai rezolválására
ATE113056T1 (de)	1994-11-15	Künstliche rezeptor-analoge.
AR020563A1 (es)	2002-05-15	Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
DK0786004T3 (da)	2001-10-22	Kloning, ekspression og karakterisering af en hidtil ukendt form af phosphatidylinositol-3-kinase
ATE128714T1 (de)	1995-10-15	Erythromycinderivate.
MX9401406A (es)	1994-08-31	Agentes receptores de adenosina selectivos para intensificar el conocimiento.
ES2162078T3 (es)	2001-12-16	Compuestos terapeuticos.
DK0571457T3 (da)	1997-07-14	Iloprost med virkning overfor cerebral malaria.
DK0809627T3 (da)	2001-11-26	Hidtil ukendte borneolderivater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
DE69323191D1 (de)	1999-03-04	Wasserlösliche retinoide